Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Withdrawn applications Remove Withdrawn applications filter Referrals Remove Referrals filter European public assessment reports (EPAR) (141) Apply European public assessment reports (EPAR) filter Summaries of opinion (4) Apply Summaries of opinion filter Paediatric investigation plans (32) Apply Paediatric investigation plans filter Orphan designations (30) Apply Orphan designations filter Direct healthcare professional communication (11) Apply Direct healthcare professional communication filter

Product number

Withdrawal type

Initial authorisation (6) Apply Initial authorisation filter Post-authorisation (2) Apply Post-authorisation filter

Withdrawal date

From:

To:

Referral name

Referral status

European Commission final decision (2) Apply European Commission final decision filter Opinion provided by Committee for Medicinal Products for Human Use (1) Apply Opinion provided by Committee for Medicinal Products for Human Use filter

Referral safety status

Yes (1) Apply Yes filter

Referral type

Article 20 procedures (3) Apply Article 20 procedures filter

Referral reference number

Referral decision making model

PRAC-CAT-CHMP-EC (1) Apply PRAC-CAT-CHMP-EC filter

Referral authorisation model

Centrally authorised product(s) (3) Apply Centrally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures (1) Apply Risk minimisation measures filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Date of opinion

From:

To:

Decision date

From:

To:

Medicine type

Biosimilar Remove Biosimilar filter Conditional approval Remove Conditional approval filter Accelerated assessment (3) Apply Accelerated assessment filter Additional monitoring (25) Apply Additional monitoring filter Exceptional circumstances (2) Apply Exceptional circumstances filter Generic (29) Apply Generic filter Orphan medicine (51) Apply Orphan medicine filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

11 results

Remove all filtersRemove all filters

Medicine type Conditional approval Remove Conditional approval filter Biosimilar Remove Biosimilar filter

Medicine Withdrawn applications Remove Withdrawn applications filter Referrals Remove Referrals filter

Categories Human Remove Human filter

Sort by

List item

Withdrawn application: Epostim

epoetin alfa, date of withdrawal: 15/03/2011, Initial authorisation, Last updated: 19/04/2011
List item

Withdrawn application: Omontys

date of withdrawal: 28/06/2013, Initial authorisation, Last updated: 28/06/2013
List item

Referral: Lartruvo

olaratumab, associated names: Lartruvo, Article 20 procedures
Status: European Commission final decision, opinion/position date: 31/01/2019, EC decision date: 19/07/2019, Last updated: 22/08/2019
List item

Withdrawn application: Memantine FGK

memantine, date of withdrawal: 18/12/2012, Initial authorisation, Last updated: 10/04/2013
List item

Withdrawn application: Teriparatide Cinnagen

teriparatide, date of withdrawal: 09/09/2021, Initial authorisation, Last updated: 17/09/2021
List item

Withdrawn application: Tuznue

trastuzumab, date of withdrawal: 14/09/2022, Initial authorisation, Last updated: 13/12/2022
List item

Withdrawn application: Hervelous

trastuzumab, date of withdrawal: 14/09/2022, Initial authorisation, Last updated: 13/12/2022
List item

Withdrawn application: Gavreto

pralsetinib, date of withdrawal: 03/11/2022, Post-authorisation, Last updated: 02/02/2023
List item

Withdrawn application: Translarna

ataluren, date of withdrawal: 06/03/2017, Post-authorisation, Last updated: 24/03/2017
List item

Referral: Zynteglo

betibeglogene autotemcel, associated names: Zynteglo, Article 20 procedures
Status: European Commission final decision, opinion/position date: 22/07/2021, EC decision date: 16/09/2021, Last updated: 08/07/2022
List item

Referral: Adakveo (updated)

crizanlizumab, associated names: Adakveo, Article 20 procedures
Status: Opinion provided by Committee for Medicinal Products for Human Use, opinion/position date: 25/05/2023, Last updated: 26/05/2023

11 results

Withdrawn application: Epostim

Withdrawn application: Omontys

Referral: Lartruvo

Withdrawn application: Memantine FGK

Withdrawn application: Teriparatide Cinnagen

Withdrawn application: Tuznue

Withdrawn application: Hervelous

Withdrawn application: Gavreto

Withdrawn application: Translarna

Referral: Zynteglo

Referral: Adakveo (updated)